AIM: To investigate the expression of p27, cyclin E and cyclin A in hepatocellular carcinoma (HCC) and its potential clinical significance. METHODS: Expression of p27, cyclin E and cyclin A in 45 HCC specimens and 30 adjacent noncancerous lesions obtained from 45 patients during surgery was examined by immunohistochemical SABC assay. The diameter of tumor ranged from 1 cm to 19 cm (d 5 cm, 9 samples; 5 cm<d 10 cm, 19 samples; d>10 cm, 17 samples). The tumors were graded according to the criteria described by Edmondson-Steiner: well-differentiated HCC group (Grade I+II), 26 samples; poorly-differentiated HCC group (Grade III+IV), 19 samples. According to the clinical-pathologic features, 19 samples were poorly encapsulated, 15 samples ...
To investigate the possible roles of p27KIP1 and p21WAF1/CIP1, inhibitors of cyclin-dependent kinase...
Objective To investigate the correlation between cyclin G1 expression and the efficacy of radiothera...
29th Congress of the International-Academy-of-Pathology -- SEP 30-OCT 05, 2012 -- Cape Town, SOUTH A...
The p27 cyclin-dependent kinase inhibitor is a negative regulator of cell-cycle progression. In many...
AIM: To investigate the expression of cell apoptosis, proliferation and the related regulators p27, ...
Background: Gastric cancer is a common digestive tract tumor in our China, with high morbidity and m...
GOALS: The purpose of this review is to look at the evidence presented in the literature on the immu...
Abstract Background Cyclin E and p27 expression is easy to assess in human tissues by standard immun...
AIM: To investigate the expression and clinical significance of DEK, cyclin D1, insulin-like growth ...
Non-alcoholic steatohepatitis (NASH) is a recently identified chronic liver disease, which progresse...
Hepatocellular carcinoma (HCC) accounts for 70-85% of liver cancer, which is the sixth most common c...
Background/Aims: The major regulatory events leading to cell proliferation occur in the G(1) phase o...
<p>A- the immunoreactivity of cyclin D1 in HCC tumor; B- the cyclin D1 immunoreactivity in fibrolame...
Abstract: Non-alcoholic steatohepatitis (NASH) is a recently identified chronic liver disease, which...
OBJECTIVE: We aimed to investigate the biological significance of cell cycle regulators in gastric c...
To investigate the possible roles of p27KIP1 and p21WAF1/CIP1, inhibitors of cyclin-dependent kinase...
Objective To investigate the correlation between cyclin G1 expression and the efficacy of radiothera...
29th Congress of the International-Academy-of-Pathology -- SEP 30-OCT 05, 2012 -- Cape Town, SOUTH A...
The p27 cyclin-dependent kinase inhibitor is a negative regulator of cell-cycle progression. In many...
AIM: To investigate the expression of cell apoptosis, proliferation and the related regulators p27, ...
Background: Gastric cancer is a common digestive tract tumor in our China, with high morbidity and m...
GOALS: The purpose of this review is to look at the evidence presented in the literature on the immu...
Abstract Background Cyclin E and p27 expression is easy to assess in human tissues by standard immun...
AIM: To investigate the expression and clinical significance of DEK, cyclin D1, insulin-like growth ...
Non-alcoholic steatohepatitis (NASH) is a recently identified chronic liver disease, which progresse...
Hepatocellular carcinoma (HCC) accounts for 70-85% of liver cancer, which is the sixth most common c...
Background/Aims: The major regulatory events leading to cell proliferation occur in the G(1) phase o...
<p>A- the immunoreactivity of cyclin D1 in HCC tumor; B- the cyclin D1 immunoreactivity in fibrolame...
Abstract: Non-alcoholic steatohepatitis (NASH) is a recently identified chronic liver disease, which...
OBJECTIVE: We aimed to investigate the biological significance of cell cycle regulators in gastric c...
To investigate the possible roles of p27KIP1 and p21WAF1/CIP1, inhibitors of cyclin-dependent kinase...
Objective To investigate the correlation between cyclin G1 expression and the efficacy of radiothera...
29th Congress of the International-Academy-of-Pathology -- SEP 30-OCT 05, 2012 -- Cape Town, SOUTH A...